EMEA-000568-PIP01-09-M06

Key facts

Invented name
Cinryze
Active substance
C1 inhibitor (human)
Therapeutic area
Immunology-Rheumatology-Transplantation
Decision number
P/0299/2015
PIP number
EMEA-000568-PIP01-09-M06
Pharmaceutical form(s)
Powder and solvent for solution for injection
Condition(s) / indication(s)
Treatment of C1 inhibitor deficiency
Route(s) of administration
Intravenous use
Contact for public enquiries
NPS Pharma Holdings Limited
United Kingdom
Tel. +80066838470
E-mail: medinfoeuceemea@shire.com
Decision type
PM: decision on the application for modification of an agreed PIP
Compliance procedure number
EMEA-C-000568-PIP01-09-M06
Compliance opinion date
26/02/2016
Compliance outcome
positive

Decision

How useful was this page?

Add your rating